Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-20-008833

EVP/Chief Scientific Officer sold 10,238 shares at an average $37.41 ($383,028)

  • EVP/Chief Scientific Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Albright Charles · EVP/Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-08-06 Exercise or conversion : show line 1 in the form +10,000 $16.51 $165,100 38,373 D
2020-08-06 Sale : show line 2 in the form −10,000 $37.47 $374,700 28,373 D
2020-08-07 Sale : show line 3 in the form −238 $34.99 $8,328 28,135 D
Open-market sales · 10,238 sh · avg $37.41 · $383,028

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-08-06 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −10,000 195,000 D
Loading xslF345X03/edgar.xml…